Todd Christopher Longsworth Insider Trading $NVCR NovoCure Ltd

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Todd Christopher Longsworth.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Todd Christopher Longsworth. Todd Christopher Longsworth is General Counsel in Novocure Ltd ($NVCR).

Todd Christopher Longsworth in NovoCure Ltd

Trading Symbol: NVCR
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Todd Christopher Longsworth: General Counsel
Holdings: 67,714 shares
Current Value: $460,455
Latest Transaction: Mar 10 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Todd Christopher Longsworth in NovoCure Ltd

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 10 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS130.812,404314,45867,71470.1 K to 67.7 K (-3.43 %)
Mar 08 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS137.553,084424,21770,11873.2 K to 70.1 K (-4.21 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA153.0919,0042,909,32219,004
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0010,342073,20262.9 K to 73.2 K (+16.45 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS152.052,355358,08562,86065.2 K to 62.9 K (-3.61 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM14.3736,396523,0110
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS179.301,200215,16159,66060.9 K to 59.7 K (-1.97 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS178.50900160,64860,86061.8 K to 60.9 K (-1.46 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS177.332,841503,79761,76064.6 K to 61.8 K (-4.40 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS176.2240070,48664,60165 K to 64.6 K (-0.62 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.282,200385,61465,00167.2 K to 65 K (-3.27 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS174.062,502435,50667,20169.7 K to 67.2 K (-3.59 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS173.101,700294,27069,70371.4 K to 69.7 K (-2.38 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.9011,9852,060,25771,40383.4 K to 71.4 K (-14.37 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.324,826826,78183,38888.2 K to 83.4 K (-5.47 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.932,542431,97088,21490.8 K to 88.2 K (-2.80 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.191,800304,54990,75692.6 K to 90.8 K (-1.94 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS167.773,500587,20992,55696.1 K to 92.6 K (-3.64 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS179.37900161,43196,05697 K to 96.1 K (-0.93 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS178.681,000178,67596,95698 K to 97 K (-1.02 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS177.312,200390,07197,956100.2 K to 98 K (-2.20 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.9840070,392100,156100.6 K to 100.2 K (-0.40 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.141,700297,731100,556102.3 K to 100.6 K (-1.66 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS173.881,600278,205102,256103.9 K to 102.3 K (-1.54 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS172.951,300224,838103,856105.2 K to 103.9 K (-1.24 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.8610,1101,737,494105,156115.3 K to 105.2 K (-8.77 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.182,761472,639115,266118 K to 115.3 K (-2.34 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.762,148364,644118,027120.2 K to 118 K (-1.79 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS168.80800135,043120,175121 K to 120.2 K (-0.66 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS167.762,499419,235120,975123.5 K to 121 K (-2.02 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM14.3736,396523,011123,47487.1 K to 123.5 K (+41.80 %)
Jul 08 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA50.4132516,38287,07886.8 K to 87.1 K (+0.37 %)
Mar 05 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA69.3737,0582,570,71337,058
Mar 05 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0019,220089,25270 K to 89.3 K (+27.44 %)
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM0.005,55605,555
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS72.222,643190,86470,03272.7 K to 70 K (-3.64 %)
Mar 02 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM79.455,556441,42472,67567.1 K to 72.7 K (+8.28 %)
Feb 26 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM0.0021,66600
Feb 26 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS81.168,482688,36567,11975.6 K to 67.1 K (-11.22 %)
Feb 26 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM88.2621,6661,912,24175,60153.9 K to 75.6 K (+40.17 %)
Jan 13 2020NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA52.58351,84053,93553.9 K to 53.9 K (+0.06 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM21.1530,414643,25686,513
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM7.1556,874406,64997,799
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM6.7211,63278,1670
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM6.7259,520399,9740
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS89.861,200107,82853,90055.1 K to 53.9 K (-2.18 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.862,900257,70355,10058 K to 55.1 K (-5.00 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.1814,8881,312,79458,00072.9 K to 58 K (-20.43 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS86.8611,426992,44072,88884.3 K to 72.9 K (-13.55 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM21.1530,414643,25684,31453.9 K to 84.3 K (+56.43 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS89.874,031362,26253,90057.9 K to 53.9 K (-6.96 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.977,869700,12957,93165.8 K to 57.9 K (-11.96 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.2224,0832,124,48265,80089.9 K to 65.8 K (-26.79 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS86.9520,8911,816,55689,883110.8 K to 89.9 K (-18.86 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM7.1556,874406,649110,77453.9 K to 110.8 K (+105.52 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS89.9740035,98853,90054.3 K to 53.9 K (-0.74 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.9492982,62254,30055.2 K to 54.3 K (-1.68 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.196,065534,89755,22961.3 K to 55.2 K (-9.89 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS86.884,238368,20661,29465.5 K to 61.3 K (-6.47 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM6.7211,63278,16765,53253.9 K to 65.5 K (+21.58 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS89.902,300206,75953,90056.2 K to 53.9 K (-4.09 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.826,616587,62056,20062.8 K to 56.2 K (-10.53 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS88.1728,3402,498,76662,81691.2 K to 62.8 K (-31.09 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS86.8522,2641,933,53991,156113.4 K to 91.2 K (-19.63 %)
Sep 05 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM6.7259,520399,974113,42053.9 K to 113.4 K (+110.43 %)
Jul 09 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA27.8169619,35753,90053.2 K to 53.9 K (+1.31 %)
Mar 26 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA47.0429,9691,409,74229,969
Mar 26 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0016,369053,20436.8 K to 53.2 K (+44.44 %)
Mar 01 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM0.005,556011,111
Mar 01 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS53.682,368127,11436,83539.2 K to 36.8 K (-6.04 %)
Mar 01 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM52.905,556293,91239,20333.6 K to 39.2 K (+16.51 %)
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM7.1511,87484,899154,673
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM7.1515,000107,250166,547
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS50.1511,874595,48121,30533.2 K to 21.3 K (-35.79 %)
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM7.1511,87484,89933,17921.3 K to 33.2 K (+55.73 %)
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS48.1515,000722,25021,30536.3 K to 21.3 K (-41.32 %)
Jan 28 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM7.1515,000107,25036,30521.3 K to 36.3 K (+70.41 %)
Jan 18 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM7.1515,000107,250181,547
Jan 18 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS45.1515,000677,25021,30536.3 K to 21.3 K (-41.32 %)
Jan 18 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM7.1515,000107,25036,30521.3 K to 36.3 K (+70.41 %)
Jan 11 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM7.1515,000107,250196,547
Jan 11 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS40.1515,000602,25021,30536.3 K to 21.3 K (-41.32 %)
Jan 11 2019NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM7.1515,000107,25036,30521.3 K to 36.3 K (+70.41 %)
Jul 10 2018NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA17.261,23121,24121,30520.1 K to 21.3 K (+6.13 %)
Mar 01 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA0.0016,667016,667
Mar 01 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA21.15121,6552,573,003121,655
Feb 26 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM0.0021,667043,333
Feb 26 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselSellS19.836,591130,68620,07426.7 K to 20.1 K (-24.72 %)
Feb 26 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselBuyM21.5521,667466,92426,6655 K to 26.7 K (+433.51 %)
Jan 31 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM6.7211,63078,15471,152
Jan 31 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselSellS24.0011,630279,1204,99816.6 K to 5 K (-69.94 %)
Jan 31 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselBuyM6.7211,63078,15416,6285 K to 16.6 K (+232.69 %)
Jan 10 2018NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselGrantA15.051662,4974,9984.8 K to 5 K (+3.44 %)
Jul 07 2017NVCRNovocure LtdLongsworth Todd ChristopherGeneral CounselGrantA6.672,81018,7514,8322 K to 4.8 K (+138.97 %)

Page:   1